Blood pressure level and kidney disease progression: Do we really need to go to 130/80 mm Hg?

被引:1
作者
Abu Jawdeh, Bassam G. [1 ]
Rahman, Mahboob [1 ]
机构
[1] Univ Hosp Case Med Ctr, Div Nephrol & Hypertens, Cleveland, OH 44106 USA
关键词
ANGIOTENSIN-CONVERTING-ENZYME; STAGE RENAL-DISEASE; DEPENDENT DIABETES-MELLITUS; 9 GENE MYH9; CARDIOVASCULAR OUTCOMES; HYPERTENSIVE PATIENTS; CLINICAL PROTEINURIA; RISK-FACTOR; FOLLOW-UP; INHIBITION;
D O I
10.1007/s11906-009-0060-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Current guidelines recommend a blood pressure goal of less than 130/80 mm Hg in patients with chronic kidney disease. Considerable epidemiologic observational data, post hoc analyses of clinical trials, and meta-analyses support this goal, particularly in patients with proteinuria. Although prospective clinical trials have not shown a clear benefit, recent data indicate that a longer duration of follow-up may be needed to assess the effects of different blood pressure goals. While we await the results of several ongoing and planned studies in this area, the current recommendations of a blood pressure goal less than 130/80 mm Hg appear reasonable.
引用
收藏
页码:363 / 367
页数:5
相关论文
共 73 条
  • [41] Mosconi L, 1996, KIDNEY INT, pS91
  • [42] Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745
  • [43] Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial
    Ogihara, Toshio
    Saruta, Takao
    Rakugi, Hiromi
    Fujimoto, Akira
    Ueshima, Kenji
    Yasuno, Shinji
    Oba, Koji
    Takeda, Kazuo
    Higaki, Jitsuo
    Nakao, Kazuwa
    [J]. HYPERTENSION RESEARCH, 2009, 32 (04) : 248 - 254
  • [44] OKAMURA M, 1991, CONTRIB NEPHROL, V90, P161
  • [45] Aliskiren combined with losartan in type 2 diabetes and nephropathy
    Parving, Hans-Henrik
    Persson, Frederik
    Lewis, Julia B.
    Lewis, Edmund J.
    Hollenberg, Norman K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (23) : 2433 - 2446
  • [46] PROTECTION OF KIDNEY-FUNCTION AND DECREASE IN ALBUMINURIA BY CAPTOPRIL IN INSULIN DEPENDENT DIABETICS WITH NEPHROPATHY
    PARVING, HH
    HOMMEL, E
    SMIDT, UM
    [J]. BRITISH MEDICAL JOURNAL, 1988, 297 (6656) : 1086 - 1091
  • [47] The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
    Parving, HH
    Lehnert, H
    Bröchner-Mortensen, J
    Gomis, R
    Andersen, S
    Arner, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 870 - 878
  • [48] The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
    Perkovic, Vlado
    Verdon, Christine
    Ninomiya, Toshiharu
    Barzi, Federica
    Cass, Alan
    Patel, Anushka
    Jardine, Meg
    Gallagher, Martin
    Turnbull, Fiona
    Chalmers, John
    Craig, Jonathan
    Huxley, Rachel
    [J]. PLOS MEDICINE, 2008, 5 (10) : 1486 - 1495
  • [49] EARLY PREDICTORS OF 15-YEAR END-STAGE RENAL-DISEASE IN HYPERTENSIVE PATIENTS
    PERRY, HM
    MILLER, JP
    FORNOFF, JR
    BATY, JD
    SAMBHI, MP
    RUTAN, G
    MOSKOWITZ, DW
    CARMODY, SE
    [J]. HYPERTENSION, 1995, 25 (04) : 587 - 594
  • [50] Blood Pressure Control Among Persons Without and With Chronic Kidney Disease US Trends and Risk Factors 1999-2006
    Plantinga, Laura C.
    Miller, Edgar R., III
    Stevens, Lesley A.
    Saran, Rajiv
    Messer, Kassandra
    Flowers, Nicole
    Geiss, Linda
    Powe, Neil R.
    [J]. HYPERTENSION, 2009, 54 (01) : 47 - 56